Fusion event
HBV-chr19 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
ACAAAAAATCAAAGAATGTTTTAGAAAACTTCCTATTAACAGGCCTATTGATTGGAAAGTATGTCAACGAATTGTGGGTCTTTTGGGTTTTGCTGCCCCT| |TTTACACAATGTGGTTATCCTGCGTTGATGCCTTTGTATGCATGTATTCAATCTAAGCAGGCTTTCACTTTCTCGCCAACTTACAAGGCCTTTCTGTGTA
End
23064091/22881289 (Hg38)
Nearest miRNA
hsa-mir-10395/Upstream/2481935; hsa-let-7e/Downstream/12241411;
Upstream sequence
atctgggctcactgcaacctccgcctctggggttcaagcaattctcctgcctcagcctcccacccaagtagctgggattataggcaggcactgccatgct
Downstream sequence
tgtgtaattttttttttttttttttttttaagtagagacagggtttcaccatgttggccaggctggtttcaaactcctgacctcaagtgatctgctcacc
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.